Improvement of physical capacity in patients undergoing transcatheter closure of atrial septal defects

@article{Prochownik2018ImprovementOP,
  title={Improvement of physical capacity in patients undergoing transcatheter closure of atrial septal defects},
  author={Paweł Prochownik and Tadeusz Przewłocki and Piotr Podolec and Piotr Wilkołek and Bartosz Sobień and Urszula Gancarczyk and Natalia Podolec and Monika Komar},
  journal={Postępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology},
  year={2018},
  volume={14},
  pages={90 - 94}
}
Introduction Atrial septal defect (ASD) is the most common congenital cardiac anomaly diagnosed in adults. It often remains asymptomatic until the fourth or fifth decade of life. Significant left-to-right interatrial shunting is associated with the risk of heart failure, pulmonary hypertension and atrial fibrillation. Percutaneous ASD closure is a recognized method of treatment. Aim To evaluate the clinical outcomes and physical capacity in patients undergoing transcatheter closure of ostium… 

Tables from this paper

Comparison of Cardiopulmonary Exercise Capacity in Patients with Atrial Septal Defect Treated with Minimally Invasive Cardiac Surgery or Transcatheter Closure

Cardiopulmonary exercise function is increased in transcatheter closure group 1 month after closure and contrary not in MICS group, which may be caused by long recovery time of the right ventricle after surgery.

Venous flow patterns after percutaneous atrial septal defect closure: Does the mechanical device decrease right atrial compliance?

Systemic venous flow patterns become abnormal and restrictive after surgical closure of ostium secundum atrial septal defect (ASD) but rarely studied after percutaneous device closure.

Percutaneous atrial septal defect closure: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society.

The joint group of experts from the Association of Cardiovascular Interventions and the Grown‑Up Congenital Heart Disease Section of the Polish Cardiac Society developed the following consensus opinion in order to standardize the principles of diagnosis, indications for treatment, methods of performing procedures, and tenets of postoperative care in Poland.

References

SHOWING 1-10 OF 14 REFERENCES

The benefit of atrial septal defect closure in elderly patients*

Closure of ASDs in elderly patients caused significant clinical and hemodynamic improvement after percutaneous treatment, which was maintained during long-term follow-up, justifying this procedure in old age.

Is it worth closing the atrial septal defect in patients with insignificant shunt?

Closure of ASD in the patients with insignificant shunt resulted in significant durable clinical and hemodynamic improvement after percutaneous treatment and the QoL improved in 7 parameters at 12-month follow-up.

Improvement in Exercise Capacity in Asymptomatic and Mildly Symptomatic Adults After Atrial Septal Defect Percutaneous Closure

Adult ASD patients significantly increase their functional capacity after percutaneous defect closure, observed even in patients classified as asymptomatic, in those with lesser shunts, and in older patients.

Transcatheter closure of atrial septal defect preserves right ventricular function

Left ventricular free wall function is unaffected by ASD closure, whereas septal function is impaired, irrespective of the method of closure, which support the transcatheter approach to ASD closure in anatomically suitable defects.

Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer ™ Septal Occluder

Abstract To judge whether an Amplatzer™ Septal Occluder can be used as standard therapy instead of surgery for closure of atrial septal defects we report our experiences in 200 patients. Of these

Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience.

The use of the new ASO is safe and effective in complete closure of secundum ASDs up to a diameter of 21 mm in the majority of patients and at a median follow-up interval of 6 mo, there have been no episodes of endocarditis, thromboembolism, or wire fracture.

Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years.

Among patients with surgically repaired atrial septal defects, those operated on before the age of 25 have an excellent prognosis, but older patients require careful, regular supervision.

Natural history of atrial septal defect.

In and after the fourth decade they approximate more closely to the figures for aortic stenosis and coarctation but are still better than those for pulmonary stenosis, and are improved on only by those with a persistent ductus.

Recent development of transcatheter closure of atrial septal defect and patent foramen ovale with occluders.

This contribution reviews the various types of occluders currently used in clinical applications and under development, including non degradable occluder, partially degradability occluding, and totally degradables.